Evidence map›Paper›PMID 29563318›Full record

ArticleScience translational medicine2018

Response to comment on "

Maximilian F Konig, Jon T Giles, Ricardo P Teles, Niki M Moutsopoulos, Felipe Andrade

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Science translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Toxins · 2022
    Review
  2. Article
  3. Exposure toJournal of clinical medicine · 2020
    Article
  4. The microbiome in autoimmune rheumatic disease.Best practice & research. Clinical rheumatology · 2020
    Review
  5. Article
  6. Rheumatoid Arthritis-Associated Mechanisms ofJournal of clinical medicine · 2019
    Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Maximilian F KonigDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0001-5045-5255
Jon T GilesDivision of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Ricardo P TelesDepartment of Periodontology, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Niki M MoutsopoulosNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
Felipe AndradeDivision of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. andrade@jhmi.edu.ORCID 0000-0003-3415-0704

Funding

Biomarkers of Periodontal Disease ProgressionU01DE021127 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI TELES, RICARDO P · 2010 to 2016
$16.2M
Inflammation and Cardiovascular Disease in Rheumatoid ArthritisR01AR050026 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI BATHON, JOAN MARIE · 2004 to 2022
$9.7M
The role of complement citrullination in RA pathogenesisR01AR069569 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ANDRADE, FELIPE · 2016 to 2020
$1.8M
Inflammation and Cardiovascular Disease in RAR55AR050026 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI BATHON, JOAN MARIE · 2003 to 2003
$100k
NIAMS NIH HHS R01 AR050026NIAMS NIH HHS R01 AR069569NIAMS NIH HHS R55 AR050026NIDCR NIH HHS U01 DE021127
6 · The paper itself

Abstract

Antibodies to leukotoxin A are markers that link

Indexed as

Arthritis, RheumatoidPeriodontitisAggregatibacter actinomycetemcomitansAutoimmunityHumans

Identifiers

PMID29563318
PMCPMC5958607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.